FY2025 · period end Dec '25 · from the 10-K filed Feb 19, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $16.86B | $13.39B | $9.09B | $11.03B | $15.03B |
| EPS (Diluted) | $10.21 | $7.95 | $5.18 | $6.15 | $8.03 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $1,420.27B | $1,215.07B | $1,193.69B | $1,180.23B | $1,188.14B |
| Total Liabilities | $1,307.62B | $1,109.64B | $1,093.71B | $1,079.00B | $1,081.54B |
| Stockholders' Equity | $112.65B | $105.43B | $99.98B | $101.23B | $106.60B |
| Cash & Equivalents | $111.69B | $105.39B | $89.23B | $128.13B | $127.72B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$17.89B | $1.36B | negative: -$33.54B | negative: -$6.40B | $33.97B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | — | — | — | — | — |
| Net Margin | — | — | — | — | — |
| Return on Equity | 15.5% | 13.0% | 9.0% | 10.6% | 14.3% |
| Return on Assets | 1.3% | 1.1% | 0.8% | 0.9% | 1.3% |
| Debt / Equity | 3.03× | 2.70× | 2.61× | 2.31× | 2.13× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000950103-26-009448 | Jun 24, 2026 | Jun 24, 2026 | Jun 24, 2026 20:52 UTC | EDGAR |
| 8-K | 0000950103-26-007291 | May 14, 2026 | May 15, 2026 | May 15, 2026 20:39 UTC | EDGAR |
| 10-Q | 0000895421-26-000121 | Mar 31, 2026 | May 5, 2026 | May 5, 2026 20:15 UTC | EDGAR |
| 8-K | 0000895421-26-000111 | Apr 15, 2026 | Apr 15, 2026 | Apr 15, 2026 11:57 UTC | EDGAR |
| 10-K | 0000895421-26-000086 | Dec 31, 2025 | Feb 19, 2026 | Feb 19, 2026 21:42 UTC | EDGAR |
| 8-K | 0000950103-26-001967 | Feb 11, 2026 | Feb 11, 2026 | Feb 11, 2026 21:19 UTC | EDGAR |
| 8-K | 0000895421-26-000007 | Jan 15, 2026 | Jan 15, 2026 | Jan 15, 2026 13:33 UTC | EDGAR |
| 10-Q | 0000895421-25-000539 | Sep 30, 2025 | Nov 3, 2025 | Nov 3, 2025 21:09 UTC | EDGAR |
Direct links to SEC EDGAR. MS has additional filings available on the SEC site.
6 numbers MORGAN STANLEY later changed — same XBRL tag, both filings linked.
Net Cash Provided by (Used in) Operating Activities·Q3 2011
Major restatementwas$3.6B
Revised up in a 10-Q. Any P/OCF built on the original was 66.6% too high.
Net Cash Provided by (Used in) Operating Activities·FY 2011
Major restatementwas$6.7B
Revised up in a 10-K. Any P/OCF built on the original was 57.9% too high.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2011
Major restatementwas$6.1B
Revised down in a 10-K.
Net Cash Provided by (Used in) Operating Activities·Q3 2017
Major restatementwas-$6.1B
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2009
Major restatementwas$857M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q3 2009
Major restatementwas$1.2B
Revised up in a 10-K.
MS is not the only one.
See every restatement we've found across the market — or get an alert the next time MS revises a number.
Restatements are detected by comparing every vintage of a fact across all of MORGAN STANLEY's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows MS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling MORGAN STANLEY — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on MS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on MS and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs